Drug therapies So-called ‘disease-modifying’ treatments, such as betainterferons and glatiramer acetate, are now available under the Department of Health’s risk-sharing scheme.
Drug therapiesSo-called ‘disease-modifying’ treatments, such as betainterferons and glatiramer acetate, are now available under the Department of Health’s risk-sharing scheme.